Search Results for "Publications Sustainability"

Excellence in Patient/Public Education Award

Excellence in Patient/Public Education Award
2015 Award Recipient
Marsha J. Komandt, RN, BSN, OCN®
Purpose 

To recognize and support excellence in patient and public education 

Award 

A $250 award, a plaque, and travel reimbursement to attend the opening ceremonies at the ONS Annual Congress

Eligibility Criteria 
Nominees for this award will be oncology nurses who are involved in offering creative public or patient education. The nominee must be an active ONS member who has been nominated by an ONS member. In addition, he or she should
  • Be a registered professional nurse
  • Have a minimum of two years experience in oncology nursing.
Application Materials 
The following materials are required.
  • Nomination narrative statement
  • Nominee's resume or curriculum vitae
  • Nominee's personal statement
  • Two (2) letters of support
Important Notice About the Nomination Deadline 

ONS uses a vendor-supported online program for all award nomination applications. At exactly 5 pm ET on September 30, the application site will automatically shut down. Any applications that are not completed at this time will be terminated and will not be accepted. This deadline cannot be extended without prior authorization from the ONS Awards advisory panel and the ONS Board of Directors.

Scoring Criteria 
The scoring criteria for judging this nomination packet is as follows.
  • Candidate teaches patients or community groups in manner consistent with the ONS Standards of Oncology Education: Patient/Family and Public.
  • Candidate identifies needs for education in patients, families, or communities and plans innovative programs to meet those identified needs.
  • Programs have clearly stated objectives.
  • Content of program(s) is relevant to population served.
  • Creative strategies and presentation techniques are used in implementing program.
  • Program evaluation methods are appropriate.
  • Candidate serves as a role model for other nurses.
  • Candidate creates a network to sustain health-promoting behaviors.
  • Candidate establishes positive teacher-learner relationships. 
Submit Your Nomination 

Submit your nomination via our online system.

Travel Information 

The recipient will receive travel reimbursement to attend the ONS Annual Congress. ONS will reimburse the award recipient for round-trip economy airfare to and from the recipient's home address to the Congress location, provided the recipient makes all travel arrangements through American Express Travel, ONS's official travel agency. Additionally, one (1) night's lodging will be permitted provided that the recipient makes the hotel arrangements through the ONS meetings department. Meals for a 24-hour period will be reimbursed, along with the reimbursement of certain ground transportation situations and parking, but there are limitations. Please contact awards@ons.org for complete details about the travel reimbursement policy.

ONS Names New Chief Executive Officer

ONS Names New Chief Executive Officer
Friday, July 11, 2014

ONS is pleased to announce that Brenda Marion Nevidjon, RN, MSN, FAAN, is named as its new chief executive officer (CEO), effective September 1.

story and image

The Oncology Nursing Society (ONS) today named Brenda Marion Nevidjon, RN, MSN, FAAN, as its new chief executive officer (CEO), effective September 1.
 
“We are excited to welcome Brenda as the new ONS CEO. Her distinguished career and leadership skill set will position ONS for the future within a complex and changing healthcare system, while achieving the ONS mission to promote excellence in oncology nursing and quality cancer care. It is an exciting time for ONS and the ONS Board of Directors,” said ONS President Margaret Barton-Burke, PhD, RN, FAAN.
 
“I am honored to be selected as the ONS CEO,” Nevidjon said. “I look forward to working with the Board, staff, members, and the larger cancer care community as we transform the provision of cancer care in a changing healthcare environment.”
 
Nevidjon is currently a professor at the Duke University School of Nursing and coordinator of the Systems Division, which includes the nursing informatics, nursing education, and nursing and healthcare leadership graduate majors. She has had an extraordinary nursing career of leadership in service and education and was the first nurse and first woman to be chief operating officer of Duke University Hospital. Through diverse clinical and administrative experiences in Canada, Switzerland, and the United States, she has devoted her energy to bridging practice settings and academic environments to advance patient care, creating innovative work environments, promoting scholarship in practitioners, and developing leaders.
 
She has helped develop professional nursing organizations at the local, national, and international levels and has made lasting contributions to ONS. Nevidjon is a past president of ONS and the ONS Foundation, has completed a term on the Institute of Medicine’s National Cancer Policy Forum Board, and has served on other cancer-related boards, most recently the Association of Community Cancer Centers and the International Society of Nurses in Cancer Care.
 
With extensive publications in the nursing literature, Nevidjon is regarded as a mentor for nurses to develop their power and voice through publication.  Her diverse contributions include two volumes of oncology nurse narratives as well as books, articles, and chapters on oncology and administrative topics, such as the role of advanced practice nurses and the nursing shortage. She consults with organizations related to work culture, team building, and leadership development. 
 
Nevidjon received the Duke School of Nursing Distinguished Alumni Award, the ONS Trish Greene Quality of Life Memorial Lectureship, and the American Nursing Association’s Honorary Recognition Award for her sustained contributions to the nursing profession. She is a graduate of the inaugural class of the Robert Wood Johnson Nurse Executive Program and the Johnson & Johnson–Wharton Fellows Program in Management for Nurse Executives and is a fellow in the American Academy of Nursing.
 

ONS Honors 2015 Distinguished Award Winners

ONS Honors 2015 Distinguished Award Winners
Wednesday, April 29, 2015

During opening ceremony of the Oncology Nursing Society's (ONS) 40th Annual Congress in Orlando, FL, renowned nursing leaders received ONS Distinguished Awards for their contributions to the field of oncology nursing. 

story and image

The Oncology Nursing Society (ONS) honored renowned nursing leaders during the opening ceremony of the ONS 40th Annual Congress in Orlando, FL. 
 
Deborah Mayer, PhD, RN, AOCN®, FAAN, received the ONS Lifetime Achievement Award for her outstanding contributions to the field of oncology nursing and to ONS. Mayer is a professor and director of cancer survivorship at the University of North Carolina (UNC) and UNC Lineberger Comprehensive Cancer Center in Chapel Hill, NC. The award recognizes Mayer for being a leader within the Society and in her community and for exemplifying the mission and core values of ONS. Mayer has consistently held leadership roles and represented oncology nursing for more than 40 years, from committee chair to mentor to editor to treasurer to president of ONS. She was a member of the National Cancer Institute’s National Cancer Advisory Board, by Presidential appointment, and of the Board of Scientific Advisors. 
 
Deborah Watkins Bruner, RN, PhD, FAAN, received the Distinguished Researcher Award in recognition of her contributions to research that have enhanced the science and practice of oncology nursing. Bruner is a Robert W. Woodruff professor of nursing, associate director of outcomes research at the Winship Cancer Center and professor of radiation oncology at Emory University in Atlanta, GA. Bruner has made outstanding contributions to advance the scientific basis for practice, has had a sustained program of substantive research, has an outstanding record for scholarly activity, has advanced the delivery of quality cancer care by nurses and physician colleagues, has developed a research program that leads the field, and has made substantive and long-lasting contributions to ONS and the cancer community.
 
Christopher Friese, RN, PhD, AOCN®, FAAN, received the Rose Mary Carroll-Johnson ONS Distinguished Award for Consistent Contributions to Nursing Literature for consistent and significant contributions to the oncology nursing literature. He is recognized for his impact on the profession, specifically using the written word to share research findings, describe content basic to the care of patients with cancer, and support the professional development of colleagues. Friese is an assistant professor at the University of Michigan School of Nursing in Ann Arbor. He is recognized for his high-quality research publications, dissemination of findings for policymakers and practitioners, and his efforts to support the professional development of colleagues. A hallmark of his work is the interdisciplinary nature of his publications, both in terms of authors and collaborators from different disciplines as well as the diversity of scientific journals. 
 
Dr. Michael Silbermann and Dr. Melissa McDiarmid received the Honorary Member Award which honors an individual who is not otherwise eligible for membership, who has made significant contributions to oncology nursing, demonstrated interest and support in ONS, and exhibited conduct consistent with our mission and core values. Silbermann is the leader of the Middle East Cancer Consortium in Haifa, Israel, and recognizes the value that nurses bring to health care. He has planned and organized courses specifically for nurses around the region and has nurses as the leaders in palliative care around the Middle East. McDiarmid, a professor at the University of Maryland School of Medicine, is recognized for her significant contributions to the science and public policy of reducing hazardous drug exposure and for advocating for the health and safety of all healthcare workers, especially those who handle hazardous drugs.
 

Pages



Menu